Skip to main content

Day: November 4, 2021

XORTX Therapeutics Clarifies Halt of Trading in Canada and Timing for Commencement of Trading on TSX Venture Exchange

CALGARY, Alberta, Nov. 04, 2021 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”) (TSXV: XRTX | NASDAQ: XRTX), a pharmaceutical therapeutics company focused on developing innovative therapies to treat progressive kidney disease, wishes to clarify that the Company’s common shares were halted on both the TSX Venture Exchange (the “TSXV”) and the Canadian Securities Exchange (the “CSE”) to finalize the de-listing procedures required on the CSE.  The common shares will be de-listed from the CSE at close of market today and the common shares will re-commence trading tomorrow, Friday, November 5, on the TSXV under the trading symbol XRTX.  Shareholders are not required to exchange their share certificates or take any other action in connection with the TSXV listing, as there will be no change in the CUSIP...

Continue reading

Hofseth Biocare ASA: THE BOARD OF DIRECTORS PROPOSES TO ELECT AMY NOVOGRATZ AS NEW DIRECTOR

Reference is made to the stock exchange notice dated 4 November 2021 on global investment fund Aqua Spark’s off-market acquisition of a 3.38 % stake in Hofseth Biocare ASA (“HBC”). In a board meeting held on 4 October 2021, the board of directors of HBC noted that Aqua Spark has shown interest in HBC over time and has carried out a thorough due diligence process of HBC prior to the investment, including on-site visits. The Board also notes that Aqua Spark is expressing intentions to be a long-term, significant shareholder in HBC and offered to nominate Amy Novogratz to the board of directors of HBC. On basis of this, the Board has decided to call for an extraordinary general meeting with a proposal that Amy Novogratz is elected to the board of directors of HBC. The notice of the extraordinary general meeting will be...

Continue reading

ExelIndustries: shares and voting rights 31.10.2021

   EXEL Industries A French public limited company (Société Anonyme) with a share capital of €16,969,750 Registered office:– France Reims Companies Register (RCS): No. B 095 550 356       Disclosure of the number of shares and voting rights comprising the share capital          Date Total number of shares comprising the share capital Total number of voting rightsOctober, 31, 2021 6 787 900 Total gross voting rights : 10 854 717Total net* voting rights : 10 608 121  * Total net amount = total amount of voting rights attached to the total number of shares minus those shares that do not carry voting rights (treasury shares).                             2.13.0.0AttachmentEXEL Industries Droits de vote 31.10.2021 EN

Continue reading

Capgemini Press Release// Capgemini and Fraunhofer IAIS lead study in Quantum Machine Learning for IT security commissioned by the German Federal Office for Information Security

Press Contact:        Joseph Hood        Tel.: +44 (0) 7385 026 260        E-Mail: joseph.hood@capgemini.com          Capgemini and Fraunhofer IAIS lead study in Quantum Machine Learning for IT security commissioned by the German Federal Office for Information Security Bonn/St. Augustin/Paris, November 4, 2021 – The German Federal Office for Information Security has commissioned Capgemini and the Fraunhofer Institute for Intelligent Analysis and Information Systems IAIS to conduct a fundamental study on Quantum Machine Learning (QML) in the context of IT security. Under the scientific leadership of Professor Christian Bauckhage from Fraunhofer IAIS, a joint team will investigate key security-related issues for the first time. Quantum Machine Learning aims to optimize classical machine learning approaches by utilizing quantum informatics....

Continue reading

SurgePays Announces Closing of Upsized $19.8 Million Public Offering, Uplisting to Nasdaq and Reverse Stock Split

BARTLETT, Tenn., Nov. 04, 2021 (GLOBE NEWSWIRE) — SurgePays, Inc. (NASDAQ: SURG, SURGW) (“SurgePays” or the “Company”), a blockchain fintech company building a next generation supply chain network that offers wholesale goods and financial services for the underbanked more cost efficiently than traditional distribution models, today announced the closing of its previously announced underwritten public offering of 4,600,000 units at a price to the public of $4.30 per unit. Each unit issued in the offering consisted of one share of common stock and one warrant to purchase one share of common stock at an exercise price of $4.73 and an expiration date of three years from the date of issuance. The common stock and warrants were immediately separable and were issued separately. The common stock and warrants began trading on the Nasdaq...

Continue reading

BALTIC HORIZON FUND CONSOLIDATED UNAUDITED INTERIM RESULTS FOR Q3 2021

Management Board of Northern Horizon Capital AS (the Management Company) has approved the unaudited consolidated interim financial statements of Baltic Horizon Fund (the Fund) for the first nine months of 2021. Baltic Horizon wins EPRA Gold awardBaltic Horizon Fund received a prestigious award at the European Public Real Estate Association (EPRA) virtual annual conference 2021 for the second year in a row. The Fund scored a “Gold Award” for the adoption of EPRA Best Practices Recommendations (BPR) – widely accepted industry standards for the highest level of transparency, comparability and compliance in financial reporting. EPRA assessed the financial statements of 181 European listed real estate entities as part of its annual award process. Extension of bank loansOn 14 July 2021, the Fund extended a EUR 7.8 million bank loan to finance...

Continue reading

BALTIC HORIZON FUND CONSOLIDATED UNAUDITED INTERIM RESULTS FOR Q3 2021

Management Board of Northern Horizon Capital AS (the Management Company) has approved the unaudited consolidated interim financial statements of Baltic Horizon Fund (the Fund) for the first nine months of 2021. Baltic Horizon wins EPRA Gold awardBaltic Horizon Fund received a prestigious award at the European Public Real Estate Association (EPRA) virtual annual conference 2021 for the second year in a row. The Fund scored a “Gold Award” for the adoption of EPRA Best Practices Recommendations (BPR) – widely accepted industry standards for the highest level of transparency, comparability and compliance in financial reporting. EPRA assessed the financial statements of 181 European listed real estate entities as part of its annual award process. Extension of bank loansOn 14 July 2021, the Fund extended a EUR 7.8 million bank loan to finance...

Continue reading

Giga-tronics to Announce Second Quarter Results and a Conference call on November 9, 2021

DUBLIN, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) — Giga-tronics Incorporated (OTCQB:GIGA) will release results for the second fiscal quarter ended September 25, 2021 on Tuesday, November 9, 2021 after the close of trading on the OTCQB Market. Also, on November 9, 2021, Giga-tronics will host a conference call at 4:30 p.m. EST to discuss results and to provide an update on Company operations. To participate in the call, dial: (888) 517-2513 or (847) 619-6533 and enter PIN Code 9015656#. It is recommended that you call in five to ten minutes prior to the start time. A replay of the call will be available later on the Giga-tronics website under “Investor Relations”. This conference call will reflect management’s views as of November 9, 2021 only. Giga-tronics produces electronic warfare test solutions used in the defense industry and...

Continue reading

Pcas:

Ecully, November 4, 2021 NET SALES AS OF SEPTEMBER 30, 2021PCAS (Euronext Paris: PCA), a specialist in developing and producing complex molecules for life sciences and innovative technologies, has announced the publication of its consolidated net sales as of September 30, 2021. The PCAS Group had generated consolidated net sales of €142.4 million as of September 30, 2021, up 0.8% compared to the same period during the previous financial year (+2.5% at constant exchange rates).In millions of euros   2021   2020   % change   2021 At a constant exchange rate   % change                     Net sales as of 30 September   142.4   141.3   0.8%   144.8   2.5%Pharmaceutical Synthesis   93.2   96.8   -3.7%   95.1   -1.8%Fine Specialty Chemicals   49.2   44.5   10.7%   49.7   11.8%Pharmaceutical Synthesis The Pharmaceutical...

Continue reading

Park Aerospace Corp. Announces That it Has Now Paid $550 Million in Cash Dividends Since the Beginning of Its 2005 Fiscal Year

NEWTON, Kan., Nov. 04, 2021 (GLOBE NEWSWIRE) — Park Aerospace Corp. announced that, with the payment of today’s regular quarterly cash dividend of $0.10 per share, the Company has paid a total of $550 million in cash dividends since the beginning of the its 2005 fiscal year. Today’s dividend was declared on September 13, 2021 and was payable to shareholders of record at the close of business on October 1, 2021. Brian Shore, Park’s Chairman and CEO, said, “$550 million in cash dividends since the beginning of our 2005 fiscal year is a heck of a lot of money for a small company like Park. And our People earned that money the old fashioned way through much hard work, sacrifice and dedication. I thought it would be nice to recognize their achievement in this news release.” Park Aerospace Corp. develops and manufactures solution and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.